Verition Fund Management LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 65 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$36,962
-85.5%
19,766
-75.6%
0.00%
-90.0%
Q1 2020$255,000
-3.0%
81,010
+673.5%
0.01%
-52.4%
Q3 2017$263,00010,4730.02%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders